Darci Jones Trader

39PUBLICATIONS
20CO-AUTHORS
Molecular targetsMedical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cellular nervous systemCell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Aug 12, 2026
From probe to prodrug: immunoproteasome activity as a trigger for disease-selective therapeutics.

|Jul 17, 2026
Two Mechanisms One Molecule: Developing a 'Truly' Bifunctional Degrader Targeting Rpn13 and CRBN.

|May 25, 2026
Control of SIINFEKL Antigen Presentation by the Immunoproteasome.

|Apr 14, 2026
In Vivo Time-Lapse Imaging Reveals Differential Activity-Induced Regulation of Proteasome Activity in Subcellular Regions of the Optic Tectum in Xenopus laevis Tadpoles.

Jessica M Lin, Benjamin Baah Konadu, Darci J Trader

|Feb 16, 2026
You are what you degrade: tracking the cellular fates of the proteasomal degradome.

Duno S Dantis, Darci J Trader

|Jan 31, 2026
Increasing Proteasome Activity to Alter XBP1 Signaling of the UPR Pathway.

Kate A Kragness, Darci J Trader

Pageof 7

Frequent Collaborators

13 joint publications

Cody A Loy

4 joint publications

Timothy J Harris

3 joint publications

Shawn E Vinogradsky

1 joint publications

Chiara Borsari